BMC Cancer

Article	Citations
Gut microbiome and its role in colorectal cancer	152
Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis	110
Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program	105
Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protoc	98
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)	88
Artificial intelligence for pre-operative lymph node staging in colorectal cancer: a systematic review and meta-analysis	84
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma	83
Robot-assisted thoracic surgery versus video-assisted thoracic surgery for lung lobectomy or segmentectomy in patients with non-small cell lung cancer: a meta-analysis	82
Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling	80
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients	79
Association between heavy metals and colon cancer: an ecological study based on geographical information systems in North-Eastern Iran	77
Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019	76
Exosomal circEIF3K from cancer-associated fibroblast promotes colorectal cancer (CRC) progression via miR-214/PD-L1 axis	75
Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma	75
Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years	70
Fusobacterium nucleatum and oral cancer: a critical review	67
Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis	65
Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database	58
Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study	58
Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population	55
Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study	54
Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer	54
Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affe	53
A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma	52
Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial)	51

A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma	51
Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results	51
PTEN loss correlates with T cell exclusion across human cancers	50
Effectiveness of clinical breast examination as a ‘stand-alone’ screening modality: an overview of systematic reviews	50
Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma	49
Designing an exercise intervention for adult survivors of childhood cancers	48
Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) rando	46
Homologous recombination proficiency in ovarian and breast cancer patients	46
Cancer incidence and mortality trends in France over 1990–2018 for solid tumors: the sex gap is narrowing	46
Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis	45
PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma	44
A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer	44
The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma	44
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review	44
Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study	42
The mixed blessing of AMPK signaling in Cancer treatments	42
Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer	42
Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis	41
CT Scans and Cancer Risks: A Systematic Review and Dose-response Meta-analysis	40
ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors	40
A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC)	39
A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis	39
The association between ATM variants and risk of breast cancer: a systematic review and meta-analysis	38
Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)	38
Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma	38
Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States	37
Risk and prognostic factors of breast cancer with liver metastases	37
Causal relationship between genetically predicted depression and cancer risk: a two-sample bi-directional mendelian randomization	37
Neutral polysaccharide from Panax notoginseng enhanced cyclophosphamide antitumor efficacy in hepatoma H22-bearing mice	37
Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer	36
Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response	36
Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study	36
The benefits and acceptability of virtual reality interventions for women with metastatic breast cancer in their homes; a pilot randomised trial	35
Pembrolizumab plus lenvatinib with or without hepatic arterial infusion chemotherapy in selected populations of patients with treatment-naive unresectable hepatocellular carcinoma exhibiting PD-L1 sta	35
Recent incidence trend of elderly patients with glioblastoma in the United States, 2000–2017	35
Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study	35
EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer	34
An M0 macrophage-related prognostic model for hepatocellular carcinoma	34
SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target	34
Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis	34
A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer	34
Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer	34
“Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study”	34
MiR-26a-5p regulates proliferation, apoptosis, migration and invasion via inhibiting hydroxysteroid dehydrogenase like-2 in cervical cancer cell	33
Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer	33
Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway	33
Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells	33
Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis	33
Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review	33
Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study	33

A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker	32
Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma	32
Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis	32
Pan-cancer analysis identifies BIRC5 as a prognostic biomarker	32
A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer	32
Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment	32
Long-term trends in colorectal cancer: incidence, localization, and presentation	31
Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients	31
Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis	31
Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma	31
Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma	31
MiR-16-5p suppresses breast cancer proliferation by targeting ANLN	31
Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma	31
Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancer	31
Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients	30
Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer	30
The role of the bacterial microbiome in the treatment of cancer	30
High HSPA8 expression predicts adverse outcomes of acute myeloid leukemia	30
Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota	30
MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma	30
The implementation of colorectal cancer screening interventions in low-and middle-income countries: a scoping review	30
Comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel including sequential treatment for metastatic pancreatic cancer: a propensity score matching approach	30
Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis	29
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells	29
Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer	29
Microbiome composition indicate dysbiosis and lower richness in tumor breast tissues compared to healthy adjacent paired tissue, within the same women	29
Feasibility of a multimodal exercise, nutrition, and palliative care intervention in advanced lung cancer	29
Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast	29
Temozolomide sensitivity of malignant glioma cell lines – a systematic review assessing consistencies between in vitro studies	29
Current lung cancer screening guidelines may miss high-risk population: a real-world study	28
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9	28
Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors	28
RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers	28
Forecasting lung cancer incidence, mortality, and prevalence to year 2030	28
Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study	28
Genetic alterations and their therapeutic implications in epithelial ovarian cancer	28
Primary effusion lymphoma occurring in the setting of transplanted patients: a systematic review of a rare, life-threatening post-transplantation occurrence	28
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial	28
Oligosaccharides increase the genotoxic effect of colibactin produced by pks+ Escherichia coli strains	28
Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer	27
Development and validation of a radiomics-based nomogram for the preoperative prediction of microsatellite instability in colorectal cancer	27
Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer	27
Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospe	27
Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis	27
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial	26
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019	26
Feasibility and safety of exercise training and nutritional support prior to haematopoietic stem cell transplantation in patients with haematologic malignancies	26
A 10-year bibliometric analysis of osteosarcoma and cure from 2010 to 2019	26
RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer	26
Mendelian randomization study of causal link from gut microbiota to colorectal cancer	26
Sniffer dogs can identify lung cancer patients from breath and urine samples	26
Deep-learning model for predicting the survival of rectal adenocarcinoma patients based on a surveillance, epidemiology, and end results analysis	26
CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy	26
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma	26
Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis	26
HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells	26
Clinical significance of p53 protein expression and TP53 variation status in colorectal cancer	26
Variceal bleeding is aggravated by portal venous invasion of hepatocellular carcinoma: a matched nested case-control study	25
Multi-vendor evaluation of artificial intelligence as an independent reader for double reading in breast cancer screening on 275,900 mammograms	25
Attention to principles of exercise training: an updated systematic review of randomized controlled trials in cancers other than breast and prostate	25
Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretion	25
Expression of hub genes of endothelial cells in glioblastoma-A prognostic model for GBM patients integrating single-cell RNA sequencing and bulk RNA sequencing	25
Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China	25
Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy	25
A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers	25
GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colo	25
Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer	25
Lympho-vascular invasion impacts the prognosis in breast-conserving surgery: a systematic review and meta-analysis	25
Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study	25
Rationale and design of the Diet Restriction and Exercise-induced Adaptations in Metastatic breast cancer (DREAM) study: a 2-arm, parallel-group, phase II, randomized control trial of a short-term, ca	25
Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation	25
A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma	25
Extracellular vesicles-derived microRNA-222 promotes immune escape via interacting with ATF3 to regulate AKT1 transcription in colorectal cancer	25
Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears	25
Catastrophic health expenditure and its determinants in households with lung cancer patients in China: a retrospective cohort study	25
No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial	25
Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort	25
Radiation-irritated skin and hyperpigmentation may impact the quality of life of breast cancer patients after whole breast radiotherapy	24
Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis	24
Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma	24

The incidence, risk factors and predictive nomograms for early death of lung cancer with synchronous brain metastasis: a retrospective study in the SEER database	24
Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review	24
AGA induces sub-G1 cell cycle arrest and apoptosis in human colon cancer cells through p53-independent/p53-dependent pathway	24
The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy	24
The risk and prognostic factors for brain metastases in esophageal cancer patients: an analysis of the SEER database	24
Clinical significance of the cachexia index in patients with small cell lung cancer	24
A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates	24
Effect of d-limonene and its derivatives on breast cancer in human trials: a scoping review and narrative synthesis	23
Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma	23
The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma	23
Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis	23
Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications	23
Restricting tumor lactic acid metabolism using dichloroacetate improves T cell functions	23
Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis	23
Development and validation of a gradient boosting machine to predict prognosis after liver resection for intrahepatic cholangiocarcinoma	23
Effectiveness of educational intervention on breast cancer knowledge and breast self-examination among female university students in Bangladesh: a pre-post quasi-experimental study	23
An integrative transcriptome analysis reveals potential predictive, prognostic biomarkers and therapeutic targets in colorectal cancer	23
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab	23
Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation	23
Unmet supportive care needs and associated factors among young adult cancer patients in Japan	23
The prognostic significance of combined geriatric nutritional risk index and psoas muscle volume in older patients with pancreatic cancer	23
Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer	23
Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients	23
COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells	23
Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK	23
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice	23
Results of the observational prospective RealFLOT study	23
Cannabinoid exposure as a major driver of pediatric acute lymphoid Leukaemia rates across the USA: combined geospatial, multiple imputation and causal inference study	23
Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale stu	23
Artificial intelligence-supported lung cancer detection by multi-institutional readers with multi-vendor chest radiographs: a retrospective clinical validation study	22
The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis	22
Global, regional, and national mortality trends of female breast cancer by risk factor, 1990–2017	22
Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases	22
Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment	22
Identification of novel hub genes associated with gastric cancer using integrated bioinformatics analysis	22
Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer	22
Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes	22
Polygenic risk prediction models for colorectal cancer: a systematic review	22
Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (T	22
DAB2IP down-regulates HSP90AA1 to inhibit the malignant biological behaviors of colorectal cancer	22
The CRCbiome study: a large prospective cohort study examining the role of lifestyle and the gut microbiome in colorectal cancer screening participants	22
Kayadiol exerted anticancer effects through p53-mediated ferroptosis in NKTCL cells	22
Nomogram-derived prediction of pathologic complete response (pCR) in breast cancer patients treated with neoadjuvant chemotherapy (NCT)	22
Identification of a four-gene panel predicting overall survival for lung adenocarcinoma	22
REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastati	22
A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma	22
Significance of KDM6A mutation in bladder cancer immune escape	21
Colorectal cancer incidence and mortality trends by sex and population group in South Africa: 2002–2014	21
Advanced lung cancer inflammation index (ALI) predicts prognosis of patients with gastric cancer after surgical resection	21
Rehabilitation interventions to support return to work for women with breast cancer: a systematic review and meta-analysis	21
LncRNA LINC00240 suppresses invasion and migration in non-small cell lung cancer by sponging miR-7-5p	21
TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway	21
Efficacy of EUS-guided FNB using a Franseen needle for tissue acquisition and microsatellite instability evaluation in unresectable pancreatic lesions	21
A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration	21
Association between the TyG index and TG/HDL-C ratio as insulin resistance markers and the risk of colorectal cancer	21
The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with loca	21
Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis	21
Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS	21
Epidemiologic patterns of biliary tract cancer in the United States: 2001–2015	21
Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma	21
Inhibitory effect of sodium butyrate on colorectal cancer cells and construction of the related molecular network	21
Knowledge, attitudes, and practice of cervical cancer prevention among health workers in rural health centres of Northern Uganda	21
Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery	21
A nomogram prediction model for lymph node metastasis in endometrial cancer patients	20
The effects of the COVID-19 pandemic on psychological stress in breast cancer patients	20
Predictive biomarkers for the efficacy of nivolumab as ≥ 3rd-line therapy in patients with advanced gastric cancer: a subset analysis of ATTRACTION-2 phase III trial	20
Identification of a pyroptosis-related prognostic signature in breast cancer	20
Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer	20
Trastuzumab administration during pregnancy: an update	20
Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia	20
MKL1 regulates hepatocellular carcinoma cell proliferation, migration and apoptosis via the COMPASS complex and NF-κB signaling	20
The relationship between the expression of Ki-67 and the prognosis of osteosarcoma	20
Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer	20
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis	20
Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma	20
Optimal biological dose: a systematic review in cancer phase I clinical trials	20
A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study	20
The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy	20
Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients	20
Exercise interventions for people diagnosed with cancer: a systematic review of implementation outcomes	20
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy	20
Synonymous mutations that regulate translation speed might play a non-negligible role in liver cancer development	20
Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma	20
Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients	20
Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea	20
Both EZH2 and JMJD6 regulate cell cycle genes in breast cancer	20
Adverse reactions of targeted therapy in cancer patients: a retrospective study of hospital medical data in China	20
Safety and efficacy profile of mogamulizumab (Poteligeo) in the treatment of cancers: an update evidence from 14 studies	20
Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer	20
Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer	20
PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers	20
High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma	20
Prevalence of multimorbidity in adults with cancer, and associated health service utilization in Ontario, Canada: a population-based retrospective cohort study	20
Palliative Gastrectomy versus Gastrojejunostomy for advanced Gastric cancer with outlet obstruction: a propensity score matching analysis	19
LncRNA WT1-AS downregulates lncRNA UCA1 to suppress non-small cell lung cancer and predicts poor survival	19